<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02385448</url>
  </required_header>
  <id_info>
    <org_study_id>UW 14-097</org_study_id>
    <nct_id>NCT02385448</nct_id>
  </id_info>
  <brief_title>Comparing the Use of Dienogest and Combined Oral Contraceptive Pills (Microgynon) to Reduce the Risk of Recurrence of Endometriotic Cyst After Conservative Surgery</brief_title>
  <official_title>A Prospective, Randomized Controlled Trial Comparing the Use of Dienogest and Combined Oral Contraceptive Pills (Microgynon) to Reduce the Risk of Recurrence of Endometriotic Cyst After Conservative Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare the recurrence of endometriotic cyst in patients
      taking Dienogest or Microgynon after conservative surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence of ovarian endometrioma</measure>
    <time_frame>2 years</time_frame>
    <description>Time to recurrence by sonography (months)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Recurrence of ovarian endometrioma</measure>
    <time_frame>2 years</time_frame>
    <description>Size of recurrent endometrioma on sonography (mean diameter in centimeters)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>2 years</time_frame>
    <description>Days of irregular bleeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptoms of endometriosis</measure>
    <time_frame>2 years</time_frame>
    <description>Pain by visual analog score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for additional analgesics</measure>
    <time_frame>2 years</time_frame>
    <description>Types of analgesics used</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Endometriosis</condition>
  <arm_group>
    <arm_group_label>Dienogest</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Combined oral contraceptive pills</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dienogest</intervention_name>
    <description>The dienogest group will receive dienogest 2mg daily for 24 months postoperatively</description>
    <arm_group_label>Dienogest</arm_group_label>
    <other_name>Visanne</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Microgynon</intervention_name>
    <description>The combined oral contraceptive pills group will be given cyclical Microgynon for 24 months.</description>
    <arm_group_label>Combined oral contraceptive pills</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Good general health

          -  Older than the age of legal consent (i.e. 18 years old)

          -  Sonographic diagnosis of ovarian endometrioma with diameter at least 4cm on 2 separate
             scans at least 6 weeks apart

          -  No contraindication to use of progesterone or combined oral contraceptive pills

          -  Not attempting to conceive either at the time of study entry or for at least 2 years
             after surgery

          -  Willing and able to participate after the study has been explained

        Exclusion Criteria:

          -  Operative findings not suggestive of endometriotic cyst

          -  Contraindications to progestogens or oral contraceptive pills

          -  Unwillingness to tolerate menstrual irregularity

          -  Planning pregnancy within 2 years of study

          -  Cannot understand English, Cantonese or Putonghua
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>51 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer K.Y. Ko, MBBS, MRCOG</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Hong Kong, Queen Mary Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jennifer K.Y. Ko, MBBS, MRCOG</last_name>
    <phone>852 22554647</phone>
    <email>jenko@hku.hk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Man Wa Lui, MBBS, MRCOG</last_name>
    <phone>852 22554647</phone>
    <email>luimanwa@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Queen Mary Hospital</name>
      <address>
        <city>Hong Kong</city>
        <zip>000000</zip>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer K.Y. Ko, MBBS, MRCOG</last_name>
      <phone>22554647</phone>
      <email>jenko@hku.hk</email>
    </contact>
    <contact_backup>
      <last_name>Ellen Lui, MBBS, MRCOG</last_name>
      <phone>22554647</phone>
      <email>luimanwa@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2015</study_first_submitted>
  <study_first_submitted_qc>March 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 11, 2015</study_first_posted>
  <last_update_submitted>April 28, 2015</last_update_submitted>
  <last_update_submitted_qc>April 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dienogest</keyword>
  <keyword>combined oral contraceptive pills</keyword>
  <keyword>endometriosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Recurrence</mesh_term>
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Contraceptive Agents</mesh_term>
    <mesh_term>Dienogest</mesh_term>
    <mesh_term>Ethinyl estradiol, levonorgestrel drug combination</mesh_term>
    <mesh_term>Ethinyl Estradiol-Norgestrel Combination</mesh_term>
    <mesh_term>Contraceptives, Oral</mesh_term>
    <mesh_term>Contraceptives, Oral, Combined</mesh_term>
    <mesh_term>Nandrolone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

